Health Economics Assignment
Added on - 28 May 2020
Showing pages 1 to 1 of 1 pages
Health EconomicsThe number of cancer patients, both male and female, will be increased and will beincreased in upcoming years. For the government of Australia, cancer treatment becomes aburden. Therefore, proper allocation of resources and planning are needed to control this disease.Lymphoma has ICD-10 cancer codes. C81 for Hodgkin’s disease, C82 for follicular non-Hodgkin’s lymphoma, C83 for diffuse non-Hodgkin’s lymphoma, C84 for peripheral andcutaneous T-cell lymphomas and C85-C86 for the types of non-Hodgkin’s lymphoma.Hodgkin cancer is a very rare type of cancer. This type of cancer especially effects peoplewith young age of an average of 40 years. Males can survive more in this diseases, compare tofemale persons.Non-Hodgkin disease is common among males in Australia. This disease can be foundamong people of an average age of 65 years.People, aged 50-54 and above, have the highest tendency to die from Leukemia.Mortality rate among makes are higher compare to females. However, children, aged between 0-4 also suffer from this disease.Total project cost for Nano Surgery is $250,000 and for Phage therapy $200,000.Comparing total employment cost of these two investments from the year 2018-19 to 2022-23, itcan be said that this cost structure is high for Nano Surgery compare to Phage therapy. Totalgoods and serivces costs are also higher for Nano surgery, compare to Phage therapy during1918-19 and 2022-23. However, the projected return from revenue is higher in Nano surgerycompare to Phage therapy during this time period.